Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gynecology

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    February 2019
  1. DELLE MARCHETTE M, Ceppi L, Andreano A, Bonazzi CM, et al
    Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery.
    Eur J Cancer. 2019;111:61-68.
    PubMed     Text format     Abstract available


  2. ANDERSSON TM, Engholm G, Lund AQ, Lourenco S, et al
    Avoidable cancers in the Nordic countries-the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer.
    Eur J Cancer. 2019;110:42-48.
    PubMed     Text format     Abstract available


  3. FRIJSTEIN MM, Lok CAR, Short D, Singh K, et al
    The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia.
    Eur J Cancer. 2019;109:162-171.
    PubMed     Text format     Abstract available


    January 2019
  4. JORGENSEN SL, Mogensen O, Wu CS, Korsholm M, et al
    Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study.
    Eur J Cancer. 2019;109:1-11.
    PubMed     Text format     Abstract available


    November 2018
  5. MENZER C, Beedgen B, Rom J, Duffert CM, et al
    Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.
    Eur J Cancer. 2018;104:239-242.
    PubMed     Text format    


    September 2018
  6. CAMPONE M, Im SA, Iwata H, Clemons M, et al
    Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.
    Eur J Cancer. 2018;103:147-154.
    PubMed     Text format     Abstract available


    July 2018
  7. BOUVARD B, Chatelais J, Soulie P, Hoppe E, et al
    Osteoporosis treatment and 10 years' oestrogen receptor+ breast cancer outcome in postmenopausal women treated with aromatase inhibitors.
    Eur J Cancer. 2018;101:87-94.
    PubMed     Text format     Abstract available


  8. BRETTHAUER M, Goderstad JM, Loberg M, Emilsson L, et al
    Uterine morcellation and survival in uterine sarcomas.
    Eur J Cancer. 2018;101:62-68.
    PubMed     Text format     Abstract available


  9. HESCOT S, Haissaguerre M, Pautier P, Kuhn E, et al
    Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.
    Eur J Cancer. 2018;97:57-58.
    PubMed     Text format    


    June 2018
  10. MEYS EMJ, Jeelof LS, Ramaekers BLT, Dirksen CD, et al
    Economic evaluation of an expert examiner and different ultrasound models in the diagnosis of ovarian cancer.
    Eur J Cancer. 2018;100:55-64.
    PubMed     Text format     Abstract available


    May 2018
  11. FRAZIER AL, Stoneham S, Rodriguez-Galindo C, Dang H, et al
    Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.
    Eur J Cancer. 2018;98:30-37.
    PubMed     Text format     Abstract available


  12. MANDALA M, Merelli B, Indriolo A, Tondini C, et al
    Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient.
    Eur J Cancer. 2018;95:130-132.
    PubMed     Text format    


    April 2018
  13. NABIEVA N, Fehm T, Haberle L, de Waal J, et al
    Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.
    Eur J Cancer. 2018;96:82-90.
    PubMed     Text format     Abstract available


  14. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.
    Eur J Cancer. 2018;95:59-67.
    PubMed     Text format     Abstract available


  15. PLOQUIN A, Pistilli B, Tresch E, Frenel JS, et al
    5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study.
    Eur J Cancer. 2018;95:30-37.
    PubMed     Text format     Abstract available


  16. MOKE DJ, Thomas SM, Hiemenz MC, Nael A, et al
    Three synchronous malignancies in a patient with DICER1 syndrome.
    Eur J Cancer. 2018;93:140-143.
    PubMed     Text format    


    January 2018
  17. PEDERSEN K, Burger EA, Nygard M, Kristiansen IS, et al
    Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Eur J Cancer. 2018;91:68-75.
    PubMed     Text format     Abstract available


  18. DUHIL DE BENAZE G, Pacquement H, Faure-Conter C, Patte C, et al
    Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
    Eur J Cancer. 2018;91:30-37.
    PubMed     Text format     Abstract available


    November 2017
  19. TIMMERMANS M, Sonke GS, Van de Vijver KK, van der Aa MA, et al
    No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
    Eur J Cancer. 2017;88:31-37.
    PubMed     Text format     Abstract available


  20. TEMKIN SM, Miller EA, Samimi G, Berg CD, et al
    Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.
    Eur J Cancer. 2017;87:182-188.
    PubMed     Text format     Abstract available


  21. ANDERSON RA, Mansi J, Coleman RE, Adamson DJA, et al
    The utility of anti-Mullerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
    Eur J Cancer. 2017;87:58-64.
    PubMed     Text format     Abstract available


    October 2017
  22. VERSLUIS MAC, Marchal S, Plat A, de Bock GH, et al
    The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
    Eur J Cancer. 2017;86:285-295.
    PubMed     Text format     Abstract available


  23. VERMEULEN RFM, Beurden MV, Kieffer JM, Bleiker EMA, et al
    Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
    Eur J Cancer. 2017;84:159-167.
    PubMed     Text format     Abstract available


    September 2017
  24. VANDERSTICHELE A, Busschaert P, Olbrecht S, Lambrechts D, et al
    Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer.
    Eur J Cancer. 2017;86:5-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: